Apyx Medical Corp. (APYX) Tops Q2 EPS by 18c

Apyx Medical Corp. (NASDAQ: APYX) reported Q2 EPS of $0.09, $0.18 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $11.4 million versus the consensus estimate of $11.69 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.

You May Also Be Interested In

• Morgan Stanley Starts Adani Enterprises Ltd. (ADE:IN) at Overweight
• Roadzen unit wins $5.3M deal to deploy AI safety on 3,600 EVs in India
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance